Text Version |Site map | Contact Us | Temple University | FAQs | Search
Prospective Students | Current Students | Faculty/Preceptors | Alumni

Why Temple School of Pharmacy

Read more...
cGMP Services
cGMP Services
Moulder Center
QA/RA

Faculty & Staff Directory

 

Ellen Walker, Ph.D.

Professor, Department of Pharmaceutical Sciences

 

3307 N. Broad Street

Philadelphia, PA 19140

office Room 515B

phone (215) 707-6770

email ellen.walker@temple.edu

Biosketch 

 

Dr. Walker is Professor of Pharmacodynamics in the Department of Pharmaceutical Sciences at the School of Pharmacy with secondary appointments in the Department of Pharmacology and in the Center for Substance Abuse Research in the School of Medicine. Dr. Walker received her bachelor's degree in Psychology (Rutgers University), master's and doctoral degrees in Biopsychology (University of Michigan) and performed postdoctoral research at Wayne State University and the University of North Carolina at Chapel Hill. For the past 25 years, her psychopharmacology research program has been supported by NIDA, NCI, and a number of state and foundation agencies to study an array of preclinical questions including the application of the quantitative principles of receptor theory to opioid, serotonin, and cannabinoid systems using various preclinical models in the fields of drug abuse, pain, obesity, and cognition. Currently, her laboratory focuses on projects investigating chemotherapy-induced adverse effects including chemotherapy-induced neuropathies, cognitive deficits, DNA damage, drug-drug interactions, and potential interventions. She has trained over 50 high school, undergraduate, professional, and graduate students in her behavioral pharmacology laboratories and published many peer-reviewed research articles. In addition, Dr. Walker is an Associate Editor for the Journal of Pharmacology and Experimental Therapeutics, is serving on two NIH study sections, and in the recent past she has served on the Advisory Board for the World Health Organization’s 34th and 36th Expert Committee on Drug Dependence.